Experimental insulin-like growth factor receptor inhibitor reduced pancreatic cancer growth
PHILADELPHIA – Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer…